The probiotics developer secured an undisclosed amount as Cargill co-led the first close of a series D round with a $55m target.

Agricultural conglomerate Cargill has co-led the first close of a $55m series D round for US-based probiotics developer Evolve BioSystems that includes medical products group Johnson & Johnson and food producer Campbell Soup. Investment firm Manna Tree co-led the tranche with Cargill, and it also featured Spruce Capital Partners, Horizons Ventures and Bow Capital, a…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.